SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed Jan 3, 2019
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2018-12-31$0.62/sh+500$312→ 32,000 total
Footnotes (1)
- [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.